{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:16:46Z","timestamp":1790630206779,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,12,19]],"date-time":"2012-12-19T00:00:00Z","timestamp":1355875200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s12185-012-1239-y","type":"journal-article","created":{"date-parts":[[2012,12,18]],"date-time":"2012-12-18T10:22:16Z","timestamp":1355826136000},"page":"30-36","source":"Crossref","is-referenced-by-count":46,"title":["Ras\/MAPK syndromes and childhood hemato-oncological diseases"],"prefix":"10.1007","volume":"97","author":[{"given":"Yoko","family":"Aoki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,19]]},"reference":[{"key":"1239_CR1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1750-1172-2-4","volume":"2","author":"I Burgt van der","year":"2007","unstructured":"van der Burgt I. Noonan syndrome. Orphanet J Rare Dis. 2007;2:4.","journal-title":"Orphanet J Rare Dis."},{"key":"1239_CR2","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1542\/peds.2009-3207","volume":"126","author":"AA Romano","year":"2010","unstructured":"Romano AA, Allanson JE, Dahlgren J, Gelb BD, Hall B, Pierpont ME, et al. Noonan syndrome: clinical features, diagnosis, and management guidelines. Pediatrics. 2010;126:746\u201359.","journal-title":"Pediatrics"},{"key":"1239_CR3","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/ajmg.1320210313","volume":"21","author":"JE Allanson","year":"1985","unstructured":"Allanson JE, Hall JG, Hughes HE, Preus M, Witt RD. Noonan syndrome: the changing phenotype. Am J Med Genet. 1985;21:507\u201314.","journal-title":"Am J Med Genet"},{"key":"1239_CR4","first-page":"397","volume":"74","author":"J Costello","year":"1971","unstructured":"Costello J. A new syndrome. N Z Med J. 1971;74:397.","journal-title":"N Z Med J."},{"key":"1239_CR5","first-page":"114","volume":"13","author":"JM Costello","year":"1977","unstructured":"Costello JM. A new syndrome: mental subnormality and nasal papillomata. Aust Paediatr J. 1977;13:114\u20138.","journal-title":"Aust Paediatr J."},{"key":"1239_CR6","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/humu.20748","volume":"29","author":"Y Aoki","year":"2008","unstructured":"Aoki Y, Niihori T, Narumi Y, Kure S, Matsubara Y. The RAS\/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders. Hum Mutat. 2008;29:992\u20131006.","journal-title":"Hum Mutat"},{"key":"1239_CR7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/ajmg.10241","volume":"108","author":"KW Gripp","year":"2002","unstructured":"Gripp KW, Scott CI Jr, Nicholson L, McDonald-McGinn DM, Ozeran JD, Jones MC, et al. Five additional Costello syndrome patients with rhabdomyosarcoma: proposal for a tumor screening protocol. Am J Med Genet. 2002;108:80\u20137.","journal-title":"Am J Med Genet"},{"key":"1239_CR8","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/ajmg.1320250303","volume":"25","author":"JF Reynolds","year":"1986","unstructured":"Reynolds JF, Neri G, Herrmann JP, Blumberg B, Coldwell JG, Miles PV, et al. New multiple congenital anomalies\/mental retardation syndrome with cardio-facio-cutaneous involvement\u2014the CFC syndrome. Am J Med Genet. 1986;25:413\u201327.","journal-title":"Am J Med Genet"},{"key":"1239_CR9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ajmg.c.30295","volume":"157","author":"JE Allanson","year":"2011","unstructured":"Allanson JE, Anneren G, Aoki Y, Armour CM, Bondeson ML, Cave H, et al. Cardio-facio-cutaneous syndrome: does genotype predict phenotype? Am J Med Genet C Semin Med Genet. 2011;157:129\u201335.","journal-title":"Am J Med Genet C Semin Med Genet."},{"key":"1239_CR10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1086\/341528","volume":"71","author":"MC Digilio","year":"2002","unstructured":"Digilio MC, Conti E, Sarkozy A, Mingarelli R, Dottorini T, Marino B, et al. Grouping of multiple-lentigines\/LEOPARD and Noonan syndromes on the PTPN11 gene. Am J Hum Genet. 2002;71:389\u201394.","journal-title":"Am J Hum Genet"},{"key":"1239_CR11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1152\/physrev.2001.81.1.153","volume":"81","author":"Y Takai","year":"2001","unstructured":"Takai Y, Sasaki T, Matozaki T. Small GTP-binding proteins. Physiol Rev. 2001;81:153\u2013208.","journal-title":"Physiol Rev"},{"key":"1239_CR12","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.gde.2009.04.001","volume":"19","author":"WE Tidyman","year":"2009","unstructured":"Tidyman WE, Rauen KA. The RASopathies: developmental syndromes of Ras\/MAPK pathway dysregulation. Curr Opin Genet Dev. 2009;19:230\u20136.","journal-title":"Curr Opin Genet Dev"},{"key":"1239_CR13","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ng1294-357","volume":"8","author":"CR Jamieson","year":"1994","unstructured":"Jamieson CR, van der Burgt I, Brady AF, van Reen M, Elsawi MM, Hol F, et al. Mapping a gene for Noonan syndrome to the long arm of chromosome 12. Nat Genet. 1994;8:357\u201360.","journal-title":"Nat Genet"},{"key":"1239_CR14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ajmg.1320530213","volume":"53","author":"I Burgt van der","year":"1994","unstructured":"van der Burgt I, Berends E, Lommen E, van Beersum S, Hamel B, Mariman E. Clinical and molecular studies in a large Dutch family with Noonan syndrome. Am J Med Genet. 1994;53:187\u201391.","journal-title":"Am J Med Genet"},{"key":"1239_CR15","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ng772","volume":"29","author":"M Tartaglia","year":"2001","unstructured":"Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, Kremer H, et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet. 2001;29:465\u20138.","journal-title":"Nat Genet"},{"key":"1239_CR16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/sj.ejhg.5200935","volume":"11","author":"L Musante","year":"2003","unstructured":"Musante L, Kehl HG, Majewski F, Meinecke P, Schweiger S, Gillessen-Kaesbach G, et al. Spectrum of mutations in PTPN11 and genotype-phenotype correlation in 96 patients with Noonan syndrome and five patients with cardio-facio-cutaneous syndrome. Eur J Hum Genet. 2003;11:201\u20136.","journal-title":"Eur J Hum Genet"},{"key":"1239_CR17","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s10038-005-0239-7","volume":"50","author":"T Niihori","year":"2005","unstructured":"Niihori T, Aoki Y, Ohashi H, Kurosawa K, Kondoh T, Ishikiriyama S, et al. Functional analysis of PTPN11\/SHP-2 mutants identified in Noonan syndrome and childhood leukemia. J Hum Genet. 2005;50:192\u2013202.","journal-title":"J Hum Genet"},{"key":"1239_CR18","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1086\/340847","volume":"70","author":"M Tartaglia","year":"2002","unstructured":"Tartaglia M, Kalidas K, Shaw A, Song X, Musat DL, van der Burgt I, et al. PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am J Hum Genet. 2002;70:1555\u201363.","journal-title":"Am J Hum Genet"},{"key":"1239_CR19","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/ng1641","volume":"37","author":"Y Aoki","year":"2005","unstructured":"Aoki Y, Niihori T, Kawame H, Kurosawa K, Ohashi H, Tanaka Y, et al. Germline mutations in HRAS proto-oncogene cause Costello syndrome. Nat Genet. 2005;37:1038\u201340.","journal-title":"Nat Genet"},{"key":"1239_CR20","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/ng1749","volume":"38","author":"T Niihori","year":"2006","unstructured":"Niihori T, Aoki Y, Narumi Y, Neri G, Cave H, Verloes A, et al. Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome. Nat Genet. 2006;38:294\u20136.","journal-title":"Nat Genet"},{"key":"1239_CR21","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1126\/science.1124642","volume":"311","author":"P Rodriguez-Viciana","year":"2006","unstructured":"Rodriguez-Viciana P, Tetsu O, Tidyman WE, Estep AL, Conger BA, Cruz MS, et al. Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome. Science. 2006;311:1287\u201390.","journal-title":"Science"},{"key":"1239_CR22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ng.497","volume":"42","author":"IC Cirstea","year":"2010","unstructured":"Cirstea IC, Kutsche K, Dvorsky R, Gremer L, Carta C, Horn D, et al. A restricted spectrum of NRAS mutations causes Noonan syndrome. Nat Genet. 2010;42:27\u20139.","journal-title":"Nat Genet"},{"key":"1239_CR23","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/ng2073","volume":"39","author":"B Pandit","year":"2007","unstructured":"Pandit B, Sarkozy A, Pennacchio LA, Carta C, Oishi K, Martinelli S, et al. Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy. Nat Genet. 2007;39:1007\u201312.","journal-title":"Nat Genet"},{"key":"1239_CR24","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/ng2078","volume":"39","author":"MA Razzaque","year":"2007","unstructured":"Razzaque MA, Nishizawa T, Komoike Y, Yagi H, Furutani M, Amo R, et al. Germline gain-of-function mutations in RAF1 cause Noonan syndrome. Nat Genet. 2007;39:1013\u20137.","journal-title":"Nat Genet"},{"key":"1239_CR25","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ng1926","volume":"39","author":"AE Roberts","year":"2007","unstructured":"Roberts AE, Araki T, Swanson KD, Montgomery KT, Schiripo TA, Joshi VA, et al. Germline gain-of-function mutations in SOS1 cause Noonan syndrome. Nat Genet. 2007;39:70\u20134.","journal-title":"Nat Genet"},{"key":"1239_CR26","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/ng1748","volume":"38","author":"S Schubbert","year":"2006","unstructured":"Schubbert S, Zenker M, Rowe SL, Boll S, Klein C, Bollag G, et al. Germline KRAS mutations cause Noonan syndrome. Nat Genet. 2006;38:331\u20136.","journal-title":"Nat Genet"},{"key":"1239_CR27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/ng1939","volume":"39","author":"M Tartaglia","year":"2007","unstructured":"Tartaglia M, Pennacchio LA, Zhao C, Yadav KK, Fodale V, Sarkozy A, et al. Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome. Nat Genet. 2007;39:75\u20139.","journal-title":"Nat Genet"},{"key":"1239_CR28","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.425","volume":"41","author":"V Cordeddu","year":"2009","unstructured":"Cordeddu V, Di Schiavi E, Pennacchio LA, Ma\u2019ayan A, Sarkozy A, Fodale V, et al. Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair. Nat Genet. 2009;41:1022\u20136.","journal-title":"Nat Genet"},{"key":"1239_CR29","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ajhg.2010.06.015","volume":"87","author":"S Martinelli","year":"2010","unstructured":"Martinelli S, De Luca A, Stellacci E, Rossi C, Checquolo S, Lepri F, et al. Heterozygous germline mutations in the CBL tumor-suppressor gene cause a Noonan syndrome-like phenotype. Am J Hum Genet. 2010;87:250\u20137.","journal-title":"Am J Hum Genet"},{"key":"1239_CR30","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/ng.641","volume":"42","author":"CM Niemeyer","year":"2010","unstructured":"Niemeyer CM, Kang MW, Shin DH, Furlan I, Erlacher M, Bunin NJ, et al. Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia. Nat Genet. 2010;42:794\u2013800.","journal-title":"Nat Genet"},{"key":"1239_CR31","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/jmg.2010.076836","volume":"47","author":"B Perez","year":"2010","unstructured":"Perez B, Mechinaud F, Galambrun C, Ben Romdhane N, Isidor B, Philip N, et al. Germline mutations of the CBL gene define a new genetic syndrome with predisposition to juvenile myelomonocytic leukaemia. J Med Genet. 2010;47:686\u201391.","journal-title":"J Med Genet"},{"key":"1239_CR32","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0968-0004(03)00091-4","volume":"28","author":"BG Neel","year":"2003","unstructured":"Neel BG, Gu H, Pao L. The \u2018Shp\u2019ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem Sci. 2003;28:284\u201393.","journal-title":"Trends Biochem Sci"},{"key":"1239_CR33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejmg.2005.03.001","volume":"48","author":"M Tartaglia","year":"2005","unstructured":"Tartaglia M, Gelb BD. Germ-line and somatic PTPN11 mutations in human disease. Eur J Med Genet. 2005;48:81\u201396.","journal-title":"Eur J Med Genet."},{"key":"1239_CR34","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/humu.20005","volume":"23","author":"A Fragale","year":"2004","unstructured":"Fragale A, Tartaglia M, Wu J, Gelb BD. Noonan syndrome-associated SHP2\/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2\/MAPK1 activation. Hum Mutat. 2004;23:267\u201377.","journal-title":"Hum Mutat"},{"key":"1239_CR35","doi-asserted-by":"crossref","first-page":"30984","DOI":"10.1074\/jbc.M504699200","volume":"280","author":"H Keilhack","year":"2005","unstructured":"Keilhack H, David FS, McGregor M, Cantley LC, Neel BG. Diverse biochemical properties of Shp2 mutants. Implications for disease phenotypes. J Biol Chem. 2005;280:30984\u201393.","journal-title":"J Biol Chem"},{"key":"1239_CR36","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1086\/499925","volume":"78","author":"M Tartaglia","year":"2006","unstructured":"Tartaglia M, Martinelli S, Stella L, Bocchinfuso G, Flex E, Cordeddu V, et al. Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease. Am J Hum Genet. 2006;78:279\u201390.","journal-title":"Am J Hum Genet"},{"key":"1239_CR37","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.febslet.2006.03.088","volume":"580","author":"N Hanna","year":"2006","unstructured":"Hanna N, Montagner A, Lee WH, Miteva M, Vidal M, Vidaud M, et al. Reduced phosphatase activity of SHP-2 in LEOPARD syndrome: consequences for PI3K binding on Gab1. FEBS Lett. 2006;580:2477\u201382.","journal-title":"FEBS Lett"},{"key":"1239_CR38","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1074\/jbc.M513068200","volume":"281","author":"MI Kontaridis","year":"2006","unstructured":"Kontaridis MI, Swanson KD, David FS, Barford D, Neel BG. PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects. J Biol Chem. 2006;281:6785\u201392.","journal-title":"J Biol Chem"},{"key":"1239_CR39","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/humu.21187","volume":"31","author":"T Kobayashi","year":"2010","unstructured":"Kobayashi T, Aoki Y, Niihori T, Cave H, Verloes A, Okamoto N, et al. Molecular and clinical analysis of RAF1 in Noonan syndrome and related disorders: dephosphorylation of serine 259 as the essential mechanism for mutant activation. Hum Mutat. 2010;31:284\u201394.","journal-title":"Hum Mutat"},{"key":"1239_CR40","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s10038-008-0343-6","volume":"53","author":"JM Ko","year":"2008","unstructured":"Ko JM, Kim JM, Kim GH, Yoo HW. PTPN11, SOS1, KRAS, and RAF1 gene analysis, and genotype-phenotype correlation in Korean patients with Noonan syndrome. J Hum Genet. 2008;53:999\u20131006.","journal-title":"J Hum Genet"},{"key":"1239_CR41","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1002\/ajmg.a.33687","volume":"152A","author":"KM Girisha","year":"2010","unstructured":"Girisha KM, Lewis LE, Phadke SR, Kutsche K. Costello syndrome with severe cutis laxa and mosaic HRAS G12S mutation. Am J Med Genet A. 2010;152A:2861\u20134.","journal-title":"Am J Med Genet A."},{"key":"1239_CR42","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/jmg.2006.046300","volume":"44","author":"M Zenker","year":"2007","unstructured":"Zenker M, Lehmann K, Schulz AL, Barth H, Hansmann D, Koenig R, et al. Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutations. J Med Genet. 2007;44:131\u20135.","journal-title":"J Med Genet"},{"key":"1239_CR43","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ccr.2004.09.022","volume":"6","author":"MJ Garnett","year":"2004","unstructured":"Garnett MJ, Marais R. Guilty as charged: B-RAF is a human oncogene. Cancer Cell. 2004;6:313\u20139.","journal-title":"Cancer Cell"},{"key":"1239_CR44","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/ajmg.a.33342","volume":"152A","author":"KA Rauen","year":"2010","unstructured":"Rauen KA, Tidyman WE, Estep AL, Sampath S, Peltier HM, Bale SJ, et al. Molecular and functional analysis of a novel MEK2 mutation in cardio-facio-cutaneous syndrome: transmission through four generations. Am J Med Genet A. 2010;152A:807\u201314.","journal-title":"Am J Med Genet A."},{"key":"1239_CR45","doi-asserted-by":"crossref","first-page":"6903","DOI":"10.1073\/pnas.95.12.6903","volume":"95","author":"LM Selfors","year":"1998","unstructured":"Selfors LM, Schutzman JL, Borland CZ, Stern MJ. soc-2 encodes a leucine-rich repeat protein implicated in fibroblast growth factor receptor signaling. Proc Natl Acad Sci USA. 1998;95:6903\u20138.","journal-title":"Proc Natl Acad Sci USA."},{"key":"1239_CR46","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.molcel.2006.03.027","volume":"22","author":"P Rodriguez-Viciana","year":"2006","unstructured":"Rodriguez-Viciana P, Oses-Prieto J, Burlingame A, Fried M, McCormick F. A phosphatase holoenzyme comprised of Shoc2\/Sur8 and the catalytic subunit of PP1 functions as an M-Ras effector to modulate Raf activity. Mol Cell. 2006;22:217\u201330.","journal-title":"Mol Cell"},{"key":"1239_CR47","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/jhg.2010.116","volume":"55","author":"S Komatsuzaki","year":"2010","unstructured":"Komatsuzaki S, Aoki Y, Niihori T, Okamoto N, Hennekam RC, Hopman S, et al. Mutation analysis of the SHOC2 gene in Noonan-like syndrome and in hematologic malignancies. J Hum Genet. 2010;55:801\u20139.","journal-title":"J Hum Genet"},{"key":"1239_CR48","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000338467","volume":"3","author":"E Denayer","year":"2012","unstructured":"Denayer E, Peeters H, Sevenants L, Derbent M, Fryns JP, Legius E. NRAS mutations in Noonan syndrome. Mol Syndromol. 2012;3:34\u20138.","journal-title":"Mol Syndromol."},{"key":"1239_CR49","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1242\/dmm.007112","volume":"4","author":"V Runtuwene","year":"2011","unstructured":"Runtuwene V, van Eekelen M, Overvoorde J, Rehmann H, Yntema HG, Nillesen WM, et al. Noonan syndrome gain-of-function mutations in NRAS cause zebrafish gastrulation defects. Dis Model Mech. 2011;4:393\u20139.","journal-title":"Dis Model Mech."},{"key":"1239_CR50","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/ajmg.c.30300","volume":"157","author":"CP Kratz","year":"2011","unstructured":"Kratz CP, Rapisuwon S, Reed H, Hasle H, Rosenberg PS. Cancer in Noonan, Costello, cardiofaciocutaneous and LEOPARD syndromes. Am J Med Genet C Semin Med Genet. 2011;157:83\u20139.","journal-title":"Am J Med Genet C Semin Med Genet."},{"key":"1239_CR51","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/MPH.0b013e3180547136","volume":"29","author":"Y Makita","year":"2007","unstructured":"Makita Y, Narumi Y, Yoshida M, Niihori T, Kure S, Fujieda K, et al. Leukemia in Cardio-facio-cutaneous (CFC) syndrome: a patient with a germline mutation in BRAF proto-oncogene. J Pediatr Hematol Oncol. 2007;29:287\u201390.","journal-title":"J Pediatr Hematol Oncol"},{"key":"1239_CR52","doi-asserted-by":"crossref","first-page":"e342","DOI":"10.1097\/MPH.0b013e3181df5e5b","volume":"33","author":"A Ohtake","year":"2011","unstructured":"Ohtake A, Aoki Y, Saito Y, Niihori T, Shibuya A, Kure S, et al. Non-hodgkin lymphoma in a patient with cardiofaciocutaneous syndrome. J Pediatr Hematol Oncol. 2011;33:e342\u20136.","journal-title":"J Pediatr Hematol Oncol"},{"key":"1239_CR53","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1182\/blood-2010-04-279083","volume":"116","author":"G Badalian-Very","year":"2010","unstructured":"Badalian-Very G, Vergilio JA, Degar BA, MacConaill LE, Brandner B, Calicchio ML, et al. Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood. 2010;116:1919\u201323.","journal-title":"Blood"},{"key":"1239_CR54","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/ajmg.a.31819","volume":"143A","author":"MM Al-Rahawan","year":"2007","unstructured":"Al-Rahawan MM, Chute DJ, Sol-Church K, Gripp KW, Stabley DL, McDaniel NL, et al. Hepatoblastoma and heart transplantation in a patient with cardio-facio-cutaneous syndrome. Am J Med Genet A. 2007;143A:1481\u20138.","journal-title":"Am J Med Genet A."},{"key":"1239_CR55","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/gcc.20735","volume":"49","author":"E Denayer","year":"2010","unstructured":"Denayer E, Devriendt K, de Ravel T, Van Buggenhout G, Smeets E, Francois I, et al. Tumor spectrum in children with Noonan syndrome and SOS1 or RAF1 mutations. Genes Chromosomes Cancer. 2010;49:242\u201352.","journal-title":"Genes Chromosomes Cancer"},{"key":"1239_CR56","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/ajmg.a.35292","volume":"158A","author":"Y Abe","year":"2012","unstructured":"Abe Y, Aoki Y, Kuriyama S, Kawame H, Okamoto N, Kurosawa K, et al. Prevalence and clinical features of Costello syndrome and cardio-facio-cutaneous syndrome in Japan: findings from a nationwide epidemiological survey. Am J Med Genet A. 2012;158A:1083\u201394.","journal-title":"Am J Med Genet A."},{"key":"1239_CR57","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/ajmg.c.30294","volume":"157","author":"KA Rauen","year":"2011","unstructured":"Rauen KA, Banerjee A, Bishop WR, Lauchle JO, McCormick F, McMahon M, et al. Costello and cardio-facio-cutaneous syndromes: moving toward clinical trials in RASopathies. Am J Med Genet C Semin Med Genet. 2011;157:136\u201346.","journal-title":"Am J Med Genet C Semin Med Genet."},{"key":"1239_CR58","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1172\/JCI43910","volume":"120","author":"PC Chen","year":"2010","unstructured":"Chen PC, Wakimoto H, Conner D, Araki T, Yuan T, Roberts A, et al. Activation of multiple signaling pathways causes developmental defects in mice with a Noonan syndrome-associated Sos1 mutation. J Clin Invest. 2010;120:4353\u201365.","journal-title":"J Clin Invest."},{"key":"1239_CR59","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1172\/JCI44929","volume":"121","author":"X Wu","year":"2011","unstructured":"Wu X, Simpson J, Hong JH, Kim KH, Thavarajah NK, Backx PH, et al. MEK\u2013ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1(L613V) mutation. J Clin Invest. 2011;121:1009\u201325.","journal-title":"J Clin Invest."},{"key":"1239_CR60","first-page":"2169","volume":"118","author":"AJ Schuhmacher","year":"2008","unstructured":"Schuhmacher AJ, Guerra C, Sauzeau V, Canamero M, Bustelo XR, Barbacid M. A mouse model for Costello syndrome reveals an Ang II-mediated hypertensive condition. J Clin Invest. 2008;118:2169\u201379.","journal-title":"J Clin Invest."},{"key":"1239_CR61","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1172\/JCI44972","volume":"121","author":"TM Marin","year":"2011","unstructured":"Marin TM, Keith K, Davies B, Conner DA, Guha P, Kalaitzidis D, et al. Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation. J Clin Invest. 2011;121:1026\u201343.","journal-title":"J Clin Invest."},{"key":"1239_CR62","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jama.300.3.287","volume":"300","author":"LC Krab","year":"2008","unstructured":"Krab LC, de Goede-Bolder A, Aarsen FK, Pluijm SM, Bouman MJ, van der Geest JN, et al. Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial. JAMA. 2008;300:287\u201394.","journal-title":"JAMA"},{"key":"1239_CR63","doi-asserted-by":"crossref","unstructured":"Takagi M, Shinoda K, Piao J, Mitsuiki N, Matsuda K, Muramatsu H, et al. Autoimmune lymphoproliferative syndrome-like disease with somatic KRAS mutation. Blood. 2011;117:2887\u201390.","DOI":"10.1182\/blood-2010-08-301515"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-012-1239-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-012-1239-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-012-1239-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T12:52:28Z","timestamp":1714740748000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-012-1239-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,19]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["1239"],"URL":"https:\/\/doi.org\/10.1007\/s12185-012-1239-y","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,19]]}}}